Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement

By Emilie Ruscoe · December 16, 2024, 10:08 PM EST

Investors in biotech company Ginkgo Bioworks Holdings Inc. have gotten final approval for their $17.75 million deal to end proposed class action claims that the company and its leaders distorted Ginkgo's...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Stuart v. Ginkgo Bioworks Holdings, Inc. et al

Case Number

4:21-cv-08943

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

November 18, 2021